Belgian politicians raise concerns on pharma regulatory data protection change

EURACTIV - In its last stretch, the Belgian Presidency of the Council of the EU is discussing regulatory data protection (RDP) for medicinal products. The goal is to balance pharmaceutical innovation with timely patient access across the EU. Read more

"Comparative clinical trials remain the gold standard, contributing to the quality of drug evaluation." - Groen party.